Immucell (ICCC) Deferred Taxes (2010 - 2020)
Immucell's (ICCC) quarterly Deferred Taxes came in at $1.0 in Q4 2020, up 100.01% YoY from $0.5 in Q1 2020, and up 100.01% on a QoQ basis from -$14632.0 in Q1 2020.
Immucell (ICCC) Deferred Taxes (2010 - 2020) Analysis & Trends
Immucell (ICCC) has 11 years of Deferred Taxes data on file, last reported at $1.0 in Q4 2020.
- Quarterly Deferred Taxes rose 100.01% year-over-year to $1.0 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was -$14631.0 (down 159.27% YoY) and the FY2020 annual result came in at -$14631.0, down 159.27% from the prior year.
- Deferred Taxes rose to $1.0 in Q4 2020, from -$14632.0 in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of $498822.0 in Q2 2018 to a low of -$293921.0 in Q4 2017.
- A 5-year average of $23547.1 and a median of -$2089.0 in 2016 frame the typical range for Deferred Taxes.
- Annual changes were most pronounced in 2017 — Deferred Taxes plunged 1667.36% — and 2018, when it soared 775.38%.
- Tracing ICCC's Deferred Taxes over 5 years: stood at $29378.0 in 2016, then plunged by 1100.48% to -$293921.0 in 2017, then soared by 104.95% to $14545.0 in 2018, then tumbled by 148.9% to -$7112.0 in 2019, then soared by 100.01% to $1.0 in 2020.
- The last three Deferred Taxes figures came in at $1.0 (Q4 2020), -$14632.0 (Q1 2020), and -$7112.0 (Q4 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -69.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 194.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.66 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Immucell | 91.19 Mn | 82.33 Mn | 2.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 1.00 |
| Mar 31, 2020 | -14,632.00 |
| Dec 31, 2019 | -7,112.00 |
| Sep 30, 2019 | 7,440.00 |
| Jun 30, 2019 | 15,333.00 |
| Mar 31, 2019 | 9,023.00 |
| Dec 31, 2018 | 14,545.00 |
| Sep 30, 2018 | -4,776.00 |
| Jun 30, 2018 | 498,822.00 |
| Mar 31, 2018 | -46,276.00 |
| Dec 31, 2017 | -293,921.00 |
| Sep 30, 2017 | -169,942.00 |
| Jun 30, 2017 | -73,858.00 |
| Mar 31, 2017 | 252,912.00 |
| Dec 31, 2016 | 29,378.00 |
| Sep 30, 2016 | -10,914.00 |
| Jun 30, 2016 | -4,179.00 |
| Mar 31, 2016 | 222,004.00 |
| Dec 31, 2015 | 141,382.00 |
| Sep 30, 2015 | 248,420.00 |